Clinical Trial Update: Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer [Phase 2]

View source ↗

Summary

Randomized Phase II study evaluating preoperative letrozole with Avastin in hormone receptor-positive breast cancer; trial terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone-sensitive Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Letrozole (letrozole)

Snippet

Sponsor: Yale University | Conditions: Hormone-Sensitive Breast Cancer, Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-03-16